Search Results

Site Search

Leveraging the Laboratory: Vision to Action - Insights

Join us for our annual Outreach Conference on Sept. 16–17, 2025, in Nashville. This year’s event, “Leveraging the Laboratory: Vision to Action,” offers a wide variety of perspectives pertaining to health system laboratory outreach programs.

Leveraging the Laboratory: Vision to Action - Insights

Join us for our annual Outreach Conference on Sept. 16–17, 2025, in Nashville. This year’s event, “Leveraging the Laboratory: Vision to Action,” offers a wide variety of perspectives pertaining to health system laboratory outreach programs.

Updates Streamline Autoimmune Neurology Testing: Anastasia Zekeridou, M.D., Ph.D. - Insights

Anastasia Zekeridou, M.D., Ph.D., explains how Mayo Clinic Laboratories' updated panels and methodology boost the accuracy and efficiency of testing for three autoimmune neurology biomarkers. Early diagnosis is key to managing debilitating...

Education - Insights

Committed to sharing knowledge The exchange of knowledge is a founding principle of Mayo Clinic. We provide a wide range of in-person, live online, and

Looking Back on Clinical Chemistry 1 - Insights

Kylie Reising, a student in the Mayo Clinic Medical Laboratory Science program, takes a look back on her Clinical Chemistry 1 course.

Oncology Testing - Mayo Clinic Laboratories

Our comprehensive test menu includes testing to aid in providing both diagnostic and prognostic information and aid in the treatment selection across the full spectrum of malignancies.

A shared journey through breast cancer: Samantha Duke and Jane Hanson - Insights

When Samantha Duke discovered she had breast cancer, she didn’t have to look far for support. Her mother Jane walked a similar path 16 years earlier. Inspired both by her mom and the strong network of healthcare physicians and professionals...

New Biomarker Greatly Improves Diagnostic Sensitivity for Rare Kidney Disease, Fibrillary Glomerulonephritis - Insights

A team of Mayo Clinic pathologists have discovered a new tissue biomarker, DNAJB9, for fibrillary glomerulonephritis, a rare kidney disease of unknown pathogenesis and poor outlook—nearly half of all patients end up on dialysis within four...

A shared journey through breast cancer: Samantha Duke and Jane Hanson - Insights

When Samantha Duke discovered she had breast cancer, she didn’t have to look far for support. Her mother Jane walked a similar path 16 years earlier. Inspired both by her mom and the strong network of healthcare physicians and professionals...

Pleural Mesothelioma - Insights

In this month's "Hot Topic," Anja Roden, M.D., a thoracic pathologist at Mayo Clinic, gives an update on the 2021 World Health Organization (WHO) classification and ancillary testing of pleural mesothelioma.